These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3802377)

  • 1. The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbits.
    Brenner DE; Collins JC; Hande KR
    Cancer Chemother Pharmacol; 1986; 18(3):219-22. PubMed ID: 3802377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography.
    Brenner DE; Galloway S; Cooper J; Noone R; Hande KR
    Cancer Chemother Pharmacol; 1985; 14(2):139-45. PubMed ID: 3971478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits.
    Harris NL; Brenner DE; Anthony LB; Collins JC; Halter S; Hande KR
    Cancer Chemother Pharmacol; 1988; 21(4):323-8. PubMed ID: 3370741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin pharmacokinetics in the rabbit.
    Maniez-Devos DM; Baurain R; Trouet A; Lesne M
    J Pharmacol; 1985; 16(2):159-69. PubMed ID: 4058012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cimetidine on cyclophosphamide metabolism in rabbits.
    Anthony LB; Long QC; Struck RF; Hande KR
    Cancer Chemother Pharmacol; 1990; 27(2):125-30. PubMed ID: 2249327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phenytoin on the pharmacokinetics of doxorubicin and doxorubicinol in the rabbit.
    Cusack BJ; Tesnohlidek DA; Loseke VL; Vestal RE; Brenner DE; Olson RD
    Cancer Chemother Pharmacol; 1988; 22(4):294-8. PubMed ID: 3168142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine.
    Johansen PB; Jensen SE; Rasmussen SN; Dalmark M
    Cancer Chemother Pharmacol; 1984; 13(1):5-8. PubMed ID: 6329539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interaction.
    Murray LS; Jodrell DI; Morrison JG; Cook A; Kerr DJ; Whiting B; Kaye SB; Cassidy J
    Clin Oncol (R Coll Radiol); 1998; 10(1):35-8. PubMed ID: 9543613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sublethal liver injury on doxorubicin metabolism.
    August DA; Halter S; Brenner DE
    Clin Cancer Res; 1995 Mar; 1(3):351-8. PubMed ID: 9815991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of allyl alcohol-induced sublethal hepatic damage upon doxorubicin metabolism and toxicity in the rabbit.
    Brenner DE; Anthony LB; Halter S; Harris NL; Collins JC; Hande KR
    Cancer Res; 1987 Jun; 47(12):3259-65. PubMed ID: 3581067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit.
    Cusack BJ; Young SP; Driskell J; Olson RD
    Cancer Chemother Pharmacol; 1993; 32(1):53-8. PubMed ID: 8462124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice.
    Webster LK; Cosson EJ; Stokes KH; Millward MJ
    Br J Cancer; 1996 Feb; 73(4):522-4. PubMed ID: 8595168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the H2-receptor antagonist cimetidine, on the pharmacokinetics and pharmacodynamics of the H1-receptor antagonists hydroxyzine and cetirizine in rabbits.
    Chen X; Simons FE; Simons KJ
    Pharm Res; 1994 Feb; 11(2):295-300. PubMed ID: 8165191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit.
    Cusack BJ; Young SP; Loseke VL; Hurty MR; Beals L; Olson RD
    Cancer Chemother Pharmacol; 1992; 30(2):145-8. PubMed ID: 1600594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin pharmacokinetics following a single-dose infusion to sulphur-crested cockatoos (Cacatua galerita).
    Gilbert CM; Filippich LJ; Charles BG
    Aust Vet J; 2004 Dec; 82(12):769-72. PubMed ID: 15648940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects.
    Ebert U; Thong NQ; Oertel R; Kirch W
    Eur J Clin Pharmacol; 2000 Jul; 56(4):299-304. PubMed ID: 10954343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cimetidine on the pharmacokinetics of 5-fluorouracil.
    Harvey VJ; Slevin ML; Dilloway MR; Clark PI; Johnston A; Lant AF
    Br J Clin Pharmacol; 1984 Sep; 18(3):421-30. PubMed ID: 6487480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ranitidine and cimetidine on imipramine disposition.
    Wells BG; Pieper JA; Self TH; Stewart CF; Waldon SL; Bobo L; Warner C
    Eur J Clin Pharmacol; 1986; 31(3):285-90. PubMed ID: 3792426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.